By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Solvay SA 

Rue du Prince Albert 33

Brussels    B-1050  Belgium
Phone: 32-0-2-509-661 Fax: 32-0-2-509-6624



Company News
CordenPharma to Acquire Peptisyntha From Solvay SA, Expanding Peptides Custom Synthesis Business 8/28/2013 10:36:26 AM
Solvay SA: Operating result from the Chemicals and Plastics activities for the third quarter of 2010 (EUR 149 million) significantly higher (+60% at constant scope 1 ) compared to the third quarter of 2009 10/28/2010 9:44:36 AM
Solvay SA to Cut 800 Jobs, Eyes 120 Mln Euro Savings 9/23/2010 6:48:12 AM
Abbott Laboratories (ABT) Puts Former Solvay SA Flu-Vaccine Business Up for Sale; Could be Worth $619 Million 6/29/2010 6:59:19 AM
Solvay SA : Operating Result In The Fourth Quarter (EUR 313 Million) Clearly Improved Compared To Last Year (EUR 125 Million) In Every Sector Of Activity; For The Year Overall, The Decrease Was Limited To 6% 2/18/2010 11:39:44 AM
Clariant Named as Possible Solvay SA Target 9/30/2009 8:25:04 AM
MediGene AG (DX:MDG) Signs Agreement with Solvay SA for the Commercialization of Veregen(R) in Germany, Austria, and Switzerland 9/29/2009 3:04:11 PM
Solvay SA : Good Resilience In Second Quarter Operating Result (EUR 164 Million), Up From The First Quarter (EUR 142 Million) 7/30/2009 10:55:38 AM
Solvay SA to Get Bids for Drug Unit Friday Say Sources 5/28/2009 7:17:47 AM
Solvay SA's 1st Quarter 2009 Results 5/12/2009 11:40:25 AM